CareCloud (CCLD) Stock Price, News & Analysis

Company Overview

CareCloud (NASDAQ: CCLD) is a leading provider of cloud-based software and services designed to streamline the administrative and clinical operations of medical practices, health systems, and ambulatory care facilities. The company’s platform combines electronic health records (EHR), practice management, revenue cycle management and patient engagement tools into a unified solution that enables healthcare providers to optimize workflow efficiency, improve financial performance and deliver a more personalized patient experience.

At the core of CareCloud’s offering is its modular suite of applications, which includes advanced charting, scheduling, billing and reporting capabilities. The EHR module supports customizable clinical templates and interoperability with major health information exchanges, while the practice management system automates appointment reminders, eligibility verification and claims adjudication. Additional services such as analytics dashboards, quality reporting and value-based care enable organizations to track performance metrics and comply with industry regulations.

Founded in 2012 by Albert Santalo, who serves as chairman and chief executive officer, CareCloud has grown through a combination of organic product development and strategic acquisitions. The company maintains its headquarters in Miami, Florida, and has established regional offices to support clients across the United States. Under Santalo’s leadership, CareCloud has emphasized user-centric design and scalability, positioning its platform to serve practices ranging from single-physician clinics to larger multi-specialty groups.

CareCloud’s cloud-native architecture allows healthcare providers to access real-time data and updates from any location, reducing IT overhead and accelerating deployment times. As the industry continues to shift toward value-based care and digital health models, CareCloud is focused on expanding its footprint through partnerships, product enhancements and international market assessments aimed at delivering end-to-end solutions that address the evolving needs of the modern healthcare ecosystem.

Key Stats

• Today's Range: $2.35 to $2.48
• 50-Day Range: $1.75 to $2.57
• 52-Week Range: $1.14 to $4.84
• Volume: 195,312 shs
• Average Volume: 401,858 shs
• Market Capitalization: $102.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.50
• Consensus Rating: Hold

CareCloud Stock Analysis - MarketRank™

CareCloud scored higher than 46% of companies evaluated by MarketBeat, and ranked 589th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

CareCloud has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

CareCloud has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 44.83%

Earnings Growth

Earnings for CareCloud are expected to grow by 44.83% in the coming year, from $0.58 to $0.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CareCloud is -11.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of CareCloud is -11.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

CareCloud has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.38% of the float of CareCloud has been sold short.

Short Interest Ratio / Days to Cover

CareCloud has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CareCloud has recently decreased by 30.85%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CareCloud does not currently pay a dividend.

Dividend Growth

CareCloud does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.38% of the float of CareCloud has been sold short.

Short Interest Ratio / Days to Cover

CareCloud has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CareCloud has recently decreased by 30.85%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: -0.28

News Sentiment

CareCloud has a news sentiment score of -0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for CareCloud this week, compared to 1 article on an average week.

Search Interest

2 people have searched for CCLD on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added CareCloud to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CareCloud insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $31,650.00 in company stock.

Percentage Held by Insiders

14.70% of the stock of CareCloud is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 10.16% of the stock of CareCloud is held by institutions.

CCLD Stock Analysis - Frequently Asked Questions

How have CCLD shares performed this year?

CareCloud's stock was trading at $3.66 at the beginning of 2025. Since then, CCLD shares have decreased by 33.9% and is now trading at $2.42.

How were CareCloud's earnings last quarter?

CareCloud, Inc. (NASDAQ:CCLD) released its quarterly earnings data on Tuesday, May, 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by $0.04. The business earned $27.60 million during the quarter, compared to the consensus estimate of $25.94 million. CareCloud had a trailing twelve-month return on equity of 24.08% and a net margin of 8.92%.
Read the conference call transcript.

How do I buy shares of CareCloud?

Shares of CCLD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CareCloud own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CareCloud investors own include CocaCola (KO), Kinder Morgan (KMI), Taiwan Semiconductor Manufacturing (TSM), Broadcom (AVGO), QUALCOMM (QCOM), Annaly Capital Management (NLY) and ONEOK (OKE).

Company Calendar

• Last Earnings: 5/06/2025
• Today: 7/08/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:CCLD
• Previous Symbol: NASDAQ:MTBCP
• CIK: 1582982
• Web: www.carecloud.com
• Phone: (732) 873-5133
• Fax: 732-873-3378
• Employees: 3,650
• Year Founded: N/A

Price Target and Rating

• Average Price Target for CareCloud: $2.50
• High Price Target: $4.50
• Low Price Target: $1.50
• Potential Upside/Downside: +3.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 4.17
• P/E Growth: N/A
• Net Income: $7.85 million
• Net Margins: 8.92%
• Pretax Margin: 9.07%
• Return on Equity: 24.08%
• Return on Assets: 16.09%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.69
• Quick Ratio: 1.65

Sales & Book Value

• Annual Sales: $110.84 million
• Price / Sales: 0.92
• Cash Flow: $1.69 per share
• Price / Cash Flow: 1.43
• Book Value: $3.06 per share
• Price / Book: 0.79

Miscellaneous

• Outstanding Shares: 42,320,000
• Free Float: 36,100,000
• Market Cap: $102.41 million
• Optionable: Optionable
• Beta: 2.06